FROM DISCOVERY TO PATIENTS
From research to diagnosis and treatment —
and to patients worldwide.
G-CoRE is an advanced medical research hub that integrates international collaborative clinical research, cancer genomics and multi-omics research, and translational research.
G-CoRE（International Center for Advanced Medical Research）
Global Center of Research Excellence on Advanced
Medicine
Keio University School of Medicine
Keio University School of Medicine
Through international collaborative clinical research and trials, and through cancer genomics and multi-omics research, we uncover the true nature of medical challenges, connecting those insights.
We are building a research infrastructure that seamlessly bridges basic research and social implementation. By integrating trial management, data science, and regulatory strategy, we deliver research results to patients swiftly and reliably. This end-to-end system is the crystallization of practical expertise we have built over many years.
Beyond that, through partnerships with research institutions and companies around the world, we bring together global wisdom, nurture the next generation of researchers, and carry these results to patients — and to medicine worldwide. From this cycle connecting research, medicine, talent, and society, we continue to create new value.
FROM DISCOVERY TO PATIENTS
Future medicine, delivered to patients today.
We pursue cutting-edge research and translate it into new diagnostics, treatments, and clinical practice.
Toward a globally leading international research hub
We design research strategy for international reach from the earliest stage, centered on global collaborative trials.
Connecting clinical care and research to create the future
We keep care, research, regulation and implementation connected — feeding clinical questions back into research.
Through international collaborative clinical research and physician-led trials, we validate the effectiveness of innovative diagnostics and therapies, working to generate evidence that becomes a global standard.
By integrating genomic and multi-omic data, we generate new insights toward realizing optimal, personalized medicine for each patient.
Through partnerships with companies and research institutions in Japan and abroad, we develop research results into technologies and products used in real-world society.
We bridge discoveries from basic research into diagnostics and therapies, accelerating the clinical application of research results.
As a research platform that fuses data science with experimental research, we provide the analysis and validation environment that supports advanced medical research.
Through hands-on international collaborative research, we train the researchers and specialists who will drive the next generation of medical innovation.
Takayuki Yoshino
Director / Professor
GI oncology & global trials. Founded SCRUM-Japan.
Masataka Amisaki
OPERATIONS LEAD
Leads day-to-day center operations.
The latest research achievements and announcements from our center members.
The Lancet Oncology Commission, in which Professor Takayuki Yoshino serves as a Commissioner, has proposed a roadmap — developed jointly with ICGC-ARGO — to close global disparities in cancer genomics and precision oncology.
An international group led by Professor Takayuki Yoshino has proposed a new framework for cancer therapeutic development based on minimal residual disease (MRD).
This section introduces representative research achievements by Director Yoshino Takayuki, together with links to the original papers.
The original paper is available via the DOI link.
For inquiries about the center, please use the link above.
